Is spray tadalafil (a phosphodiesterase type 5 inhibitor, brand name Cialis) a real and approved formulation for treating erectile dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Spray Tadalafil Real?

No, spray tadalafil is not an FDA-approved or guideline-recognized formulation for treating erectile dysfunction. Tadalafil is only approved and recommended in oral tablet form, either as on-demand dosing (10-20 mg) or daily dosing (2.5-5 mg) 1, 2.

Approved Formulations of Tadalafil

  • Tadalafil is administered orally as tablets and is established as first-line therapy for erectile dysfunction by the American Urological Association and American College of Physicians 1, 2
  • The only approved dosing strategies are oral tablets taken on-demand (10 mg or 20 mg) or once-daily (2.5-5 mg), with no spray formulation recognized in clinical guidelines 2, 3
  • For benign prostatic hyperplasia with or without erectile dysfunction, tadalafil 5 mg once daily is the FDA-approved oral dose 3

Research on Spray Formulations

  • One research study from 2020 investigated spray-dried amorphous solid dispersions of tadalafil using glycyrrhizin as a carrier to enhance dissolution rates in rats, but this was a pharmaceutical development study, not a clinically approved product 4
  • This experimental formulation showed improved dissolution rates (4.07-fold increase) and aphrodisiac activity in male rats, but it remains an investigational compound with no human clinical trials or regulatory approval 4

Why Oral Tablets Remain the Standard

  • High-quality evidence demonstrates that oral tadalafil tablets achieve 69% successful sexual intercourse attempts versus 33% with placebo, with proven efficacy across all severities and etiologies of erectile dysfunction 1, 2
  • The long half-life of 17.5 hours with oral tadalafil provides a therapeutic window of up to 36 hours, eliminating the need for alternative delivery methods 2, 5
  • Oral tadalafil has been extensively studied in diverse populations including men with diabetes, cardiovascular disease, post-prostatectomy, and other comorbidities, with established safety profiles 1, 2

Critical Safety Concerns with Unapproved Products

  • Any non-FDA-approved formulation of tadalafil, including sprays, carries unknown risks regarding dosing accuracy, absorption rates, and potential for dangerous drug interactions, particularly with nitrates which can cause fatal hypotension 2
  • Patients must be explicitly counseled that only oral tablet formulations have undergone rigorous safety testing and regulatory approval 2

If patients encounter spray tadalafil products online or elsewhere, they should be advised these are not legitimate pharmaceutical products and may pose serious health risks.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tadalafil for Erectile Dysfunction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Tadalafil Dosing and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Development of spray-dried amorphous solid dispersions of tadalafil using glycyrrhizin for enhanced dissolution and aphrodisiac activity in male rats.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2020

Research

Tadalafil in the treatment of erectile dysfunction.

Therapeutics and clinical risk management, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.